Science Business Insider - "One of the most significant science breakthroughs of 2013"

World Economic Forum - "Microbiome one of Top 10 Emerging Technologies in 2014"

Targetting:

* Obesity

* Cholesterol

* Diabetes

* ...Many more to come.


Key points:

* Food additives not drugs - less regulation thus much quicker and cheaper route to market.

* Shares in issue 72 million - only 45% free float.

* Already talking to DuPont, Kraft Foods, GSK etc.

* Multiple product, Multiple partner opportunities.

* £3m cash - enough for 2+ years.

* 4D Pharma in same field valued at £180m (opti valued at £9m)

Early morning RNS.
very positive says Mr O'Hara.